Market closure-
04:00:00 2025-03-07 PM |
5 days change |
January 1 change |
||
1.580 USD |
-34.44% |
|
-40.38% | -73.88% |
March 6, 2025 at 10:38 am EST

© MT NEWSWIRES -2025
Scienture Unit, Summit Biosciences cooperation to launch Naloxone spray for overdose of opioids in the United States |
March 06 |
mountain |
Science that is commercially commercially available |
March 06 |
Reply |
Scienture Holdings, Inc. have announced the resignation. |
January 17th |
Ci |
Scienture files where shareholders can sell up to 4.3 million common stocks |
December 4th |
mountain |
Scienture Holdings, Inc. expects to receive $ 1,222222 million from Arena Business Solutions Global SPC II and LTD. |
November 21st |
Ci |
Scienture Holdings, Inc. reports the results of imports of 3Q and 9 months on September 30, 2024. |
November 06 |
Ci |
Scienture Holdings, Inc. The auditor raises the doubt ‘there is room for doubt’ |
24-09-24 |
Ci |
Scienture Holdings, Inc. (NASDAQCM: SCNX) has been added to the NASDAQ composite index. |
24-09-23 |
Ci |
Scienture Holdings, Inc. |
24-09-23 |
Ci |
Trxade Health, Inc. has changed the name to Scienture Holdings, Inc. |
24-09-23 |
Ci |
Trxade Health changes its name to Scienture Holdings |
24-09-20 |
mountain |
Trxade Health, Inc. (NASDAQCM: Meds) fell from the NASDAQ composite index. |
24-09-19 |
Ci |
Trxade Health, Inc. will report the results of the second and six months of imports on June 30, 2024. |
24-08-28 |
Ci |
Scienture Holdings, Inc. reports the results of the second and six months of imports on June 30, 2024. |
24-08-09 |
Ci |
Trxade Health, Inc. And scienture, LLC announced the change of management. |
24-08-05 |
Ci |
Trxade Health, Scienture Complete Business Combination; Trxade shared jump |
24-07-26 |
mountain |
Scienture Inc. has acquired Trxade Health, Inc. in a reverse merger transaction in a $ 133 million transaction. |
24-07-25 |
Ci |
TRXADE HEALTH, INC. announced on May 28, 2021. |
24-06-26 |
Ci |
Trxade Health, Inc. will report import results in the first quarter on March 31, 2024. |
24-06-26 |
Ci |
Trxade Health, Inc. has announced the change of board. |
24-06-20 |
Ci |
Trxade Health, Inc. has announced the change of board. |
24-05-30 |
Ci |
TRXADE HEALTH, INC. announced on May 28, 2021. |
24-04-22 |
Ci |
Trxade Health, Inc. Reporting results of the year ended on December 31, 2023 |
24-04-22 |
Ci |
The best noon gain |
24-03-06 |
mountain |
Superlatus Foods, Inc. have acquired superlatus, Inc for $ 1 at Trxade Health, Inc. |
24-03-05 |
Ci |
SCNX: Dynamic Chart
Previous Trxade Health, Inc. Incienture Holdings, Inc. is a comprehensive health service, and pharmaceutical products are a pharmaceutical company that focuses on providing new special products to provide new special products and providing new special products to optimize US prescription travel and patient participation. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture and LLC are branded pharmaceutical companies. The assets under development spend the area of treatment, indications and other market sectors. The product includes SCN -102 (Cardiovascular), SCN -104 (CNS -PAIN), SCN -105 (CNS), SCN -106 (Cardiovascular) and SCN -107 (Pain). Integra Pharma Solutions, LLC is a pharmaceutical supplier for medical organizations of all scale. The expertise of product distribution is expanded to all medical markets, including government agencies, hospitals, clinics and independent pharmacies nationwide.
More details about the company